Inventor
PAULDING CHARLES
US6 patents
Patents
6 patentsUS12571027B2Mar 10, 2026
Methods of associating genetic variants with a clinical outcome in patients suffering from age-related macular degeneration treated with anti-VEGF
REGENERON PHARMA0 citations56
US12264366B2Apr 1, 2025
Genome-based methods for reducing cardiovascular risk
REGENERON PHARMA0 citations56
US12116622B2Oct 15, 2024
Methods of associating genetic variants with a clinical outcome in patients suffering from age-related macular degeneration treated with anti-VEGF
REGENERON PHARMA0 citations56
US11769597B2Sep 26, 2023
Methods of associating genetic variants with a clinical outcome in patients suffering from age-related macular degeneration treated with anti-VEGF
REGENERON PHARMA0 citations56
US11519020B2Dec 6, 2022
Methods of associating genetic variants with a clinical outcome in patients suffering from age-related macular degeneration treated with anti-VEGF
REGENERON PHARMA0 citations56
US12378557B2Aug 5, 2025
Treatment of sepsis with PCSK9 and LDLR modulators
REGENERON PHARMA0 citations46